Rabies Post-Exposure Prophylaxis Protocol for a 22-Year-Old Male
For a previously unvaccinated 22-year-old male with potential rabies exposure, immediately initiate post-exposure prophylaxis (PEP) consisting of thorough wound cleansing, rabies immune globulin (HRIG) 20 IU/kg infiltrated into and around the wound, and a 4-dose vaccine series administered intramuscularly in the deltoid on days 0,3,7, and 14. 1
Initial Assessment Priorities
When evaluating this patient, you need to determine:
1. Exposure Risk Assessment
Type of exposure: Was there a bite, scratch, or contact with saliva/neural tissue on broken skin or mucous membranes? Non-bite exposures (scratches, abrasions, open wounds, mucous membranes contaminated with saliva) also warrant PEP 2
Animal species involved:
Circumstances of the incident:
- Unprovoked attacks are more concerning than provoked attacks
- Geographic location matters—rabies epidemiology varies by region 2
Animal availability: Can the animal be captured for observation or testing? A healthy dog, cat, or ferret can be confined and observed for 10 days rather than immediately starting PEP 2
2. Prior Vaccination History
Critical question: Has the patient ever received a complete rabies vaccination series (either pre-exposure or post-exposure)?
- If previously vaccinated: Give only 2 vaccine doses (days 0 and 3), no HRIG 1
- If never vaccinated: Full PEP protocol required 2
3. Immunosuppression Status
Ask about HIV, immunosuppressive medications, chemotherapy, or other conditions affecting immunity. Immunocompromised patients require a 5-dose vaccine schedule (days 0,3,7,14, and 28) instead of the standard 4-dose regimen 1
Treatment Protocol for Previously Unvaccinated Patients
Step 1: Immediate Wound Care
- Thoroughly cleanse all wounds with soap and water
- Irrigate with dilute povidone-iodine solution if available
- This is critical: Wound cleansing alone markedly reduces rabies risk in animal studies 2
- Avoid suturing when possible 2
- Consider tetanus prophylaxis 2
Step 2: HRIG Administration (Day 0)
- Dose: 20 IU/kg body weight (0.133 mL/kg) 2
- Technique: Infiltrate the full dose around and into the wound(s) if anatomically feasible
- Any remaining volume should be injected IM at a site distant from the vaccine injection site 2
- Never administer HRIG in the same syringe or same anatomical site as the vaccine 2
- Timing: HRIG can be given up to day 7 of the vaccine series if not given initially, but beyond day 7 it should not be administered 2
Common pitfall: Do not exceed the recommended HRIG dose—excess can suppress active antibody production 2
Step 3: Vaccine Administration
For immunocompetent patients: 4-dose series 1
- Day 0 (same day as HRIG, different site)
- Day 3
- Day 7
- Day 14
Site: Deltoid muscle for adults (never gluteal area—results in lower antibody titers) 2
Vaccines available: Human diploid cell vaccine (HDCV) or purified chick embryo cell vaccine (PCECV), 1.0 mL IM per dose 1
Special Circumstances
If the Animal Becomes Available for Testing
If the animal is captured and tests negative by direct fluorescent antibody test, discontinue PEP immediately 2. No failures have been documented with current biologics when properly administered 2
Schedule Deviations
Minor delays of a few days are acceptable—simply resume the schedule maintaining the same intervals between doses. For example, if the day 7 dose is missed and the patient presents on day 10, give that dose and continue with remaining doses at the proper intervals 2
Travel-Related Exposures
If the patient received PEP abroad with non-U.S. approved vaccines or regimens, contact your state/local health department for guidance on whether additional prophylaxis is needed 2
Key Clinical Pitfalls to Avoid
Don't dismiss bat exposures without obvious bites: Most U.S. human rabies cases result from bat variants, often without recognized bites 2
Don't delay: PEP is a medical urgency (not emergency), but decisions should not be delayed. Even exposures with long incubation periods warrant prophylaxis 2
Don't give HRIG after day 7: It can suppress active antibody production and is unnecessary once vaccine-induced immunity begins 2
Don't use the gluteal site for vaccination: Results in inadequate antibody response 2
Don't forget the 5-dose schedule for immunocompromised patients: The standard 4-dose regimen is insufficient 1